Healthcare


 Genetic Technologies Releases Investor Presentation Report

Genetic Technologies Releases Investor Presentation Report

March 20, 2019 10:03 PM AEDT| By Team Kalkine Media

Molecular Diagnostic Company Genetic Technologies Limited (ASX: GTG) is an ASX and NASDAQ (GENE) listed company with specialization in women?s health through its predictive testing and assessment tools. Its product BREVAGenplus? helps in assessing no...

 Imugene provides Guidance for KEY-Vaxx Cancer Immunotherapy

Imugene provides Guidance for KEY-Vaxx Cancer Immunotherapy

March 20, 2019 07:31 PM AEDT| By Team Kalkine Media

Imugene Limited (ASX: IMU) is an ASX listed biotechnology company based in Sydney, Australia. The company?s primary focus is on the cancer immunotherapy by developing a range of new and novel immunotherapies that can activate the immune system of can...

 Healthscope Limited Gets FIRB Approval For Brookfield Transaction

Healthscope Limited Gets FIRB Approval For Brookfield Transaction

March 20, 2019 06:36 PM AEDT| By Team Kalkine Media

Healthscope Limited (ASX: HSO) provides healthcare services. The Company manages a network of hospitals, clinics, and physicians for the provision of emergency care, women's facilities, cancer care, and pediatric services. Healthscope serves customer...

 Blackmores Announces The Change In Leadership Structure Following The Resignation Of CEO

Blackmores Announces The Change In Leadership Structure Following The Resignation Of CEO

March 20, 2019 04:41 PM AEDT| By Team Kalkine Media

Blackmores Limited (ASX: BKL) today confirmed the resignation of Richard Henfrey who will step down as a Chief Executive Officer and Managing Director of the company with effect from 29 March 2019. The news sent the stock price to dip by 1.312% to st...

 SUDA Pharmaceuticals develops oral spray product for cancer prevention

SUDA Pharmaceuticals develops oral spray product for cancer prevention

March 20, 2019 03:27 PM AEDT| By Team Kalkine Media

A drug-delivery pharmaceutical company, SUDA Pharmaceuticals has recently identified the use of platelets as surrogate biomarkers in cancer risk that can potentially reduce the economic burden from cancer incidence at risk individuals. SUDA Pharmace...

 5 Most Talked About Stocks In Healthcare Space - CYP, MSB, MMJ, HSO And NAN

5 Most Talked About Stocks In Healthcare Space - CYP, MSB, MMJ, HSO And NAN

March 19, 2019 07:30 PM AEDT| By Team Kalkine Media

Cynata Therapeutics Limited The Carlton-based Cynata Therapeutics Limited (ASX: CYP) is a clinical-stage biotechnology company engaged in developing and commercialising its flagship product Cymerus, based on its proprietary mesenchymal stem cell te...

 Immuron updates about drug candidate IMM-529; obtains new US patent from USPTO

Immuron updates about drug candidate IMM-529; obtains new US patent from USPTO

March 19, 2019 06:29 PM AEDT| By Team Kalkine Media

Immuron Limited (ASX: IMC) is an Australian based biopharmaceutical company. It is engaged with marketing and selling of Travelan in Australia for the prevention of Travellers? Diarrhea. IMC also markets it in the USA and Canada as a dietary suppleme...

 Kazia Therapeutics Sells Its Remaining Stake in Noxopharm; Gross Proceeds From Sale Amounts To $2.4 Million

Kazia Therapeutics Sells Its Remaining Stake in Noxopharm; Gross Proceeds From Sale Amounts To $2.4 Million

March 19, 2019 03:38 PM AEDT| By Team Kalkine Media

The Sydney based oncology-focused biotech company, Kazia Therapeutics Limited (ASX: KZA) today announced that it has entered into an arrangement to sell the remainder of its holding in the shares of Noxopharm limited (ASX: NOX) via a block trade. Th...

 Cann Group’s shares surged 19% on a Revised Expansion Plan and Offtake Agreement

Cann Group’s shares surged 19% on a Revised Expansion Plan and Offtake Agreement

March 19, 2019 02:41 PM AEDT| By Team Kalkine Media

Cann Group Limited (ASX: CAN) is one of the few companies which is trying to tap the medical cannabis market by providing access to medicinal cannabis for patients. It was issued the first medicinal cannabis research licence and first medicinal canna...

 ResApp Health announced significant outcomes obtained from SMARTCOUGH-C-2 Study

ResApp Health announced significant outcomes obtained from SMARTCOUGH-C-2 Study

March 18, 2019 08:00 PM AEDT| By Team Kalkine Media

The leading digital healthcare company, ResApp Health Limited (ASX: RAP) declared the top-line outcomes for croup and primary upper respiratory tract disease (URTD) attained from the study of SMARTCOUGH-C-2. SMARTCOUGH-C-2 is a double-blind, prospec...

 Rhythm Biosciences Recruits First Patient At ColoSTAT’s Lyell McEwin Study Site

Rhythm Biosciences Recruits First Patient At ColoSTAT’s Lyell McEwin Study Site

March 18, 2019 06:27 PM AEDT| By Team Kalkine Media

The Melbourne-based Rhythm Biosciences Limited (ASX: RHY), established in 2017, is a company that develops and commercialises a screening and diagnostic tool for the early stage detection of colorectal cancer in the global mass market. Its flagship p...

 Jayex Healthcare Is All Set To Capture New Zealand Cannabis Market With Its Revised Strategy

Jayex Healthcare Is All Set To Capture New Zealand Cannabis Market With Its Revised Strategy

March 18, 2019 05:56 PM AEDT| By Team Kalkine Media

Jayex Healthcare Limited (ASX: JHL) is in the business of healthcare sector. The company has specifically focused on healthcare technology from the last 25 years by creating several products and acquiring Australia?s number one appointment booking ap...

 Alcidion Group Announces ~$2.1 Mn Deal With Dartford And Gravesham NHS Trust

Alcidion Group Announces ~$2.1 Mn Deal With Dartford And Gravesham NHS Trust

March 18, 2019 05:16 PM AEDT| By Team Kalkine Media

Alcidion Group Limited (ASX: ALC) announced a strategic partnership worth ~$2.1 Mn with Dartford and Gravesham NHS trust in the UK, over a period of 5 years. The trust will be Alcidion?s first customer outside Australia to adopt its complete product...

 Pro Medicus Releases Investor Presentation – Stock Price Surged Over 4% On ASX

Pro Medicus Releases Investor Presentation – Stock Price Surged Over 4% On ASX

March 18, 2019 03:14 PM AEDT| By Team Kalkine Media

Pro Medicus Limited (ASX: PME) is a healthcare IT company with leading-edge products and with global presence specializing in Enterprise imaging and radiology information system (RIS) software. It today announced half-yearly 2019 results, where it r...

 Prana Biotechnology Receives $3.3 Million Tax Incentive Refund

Prana Biotechnology Receives $3.3 Million Tax Incentive Refund

March 18, 2019 02:43 PM AEDT| By Team Kalkine Media

ASX-listed biotech company Prana Biotechnology Limited (ASX: PBT) received a Research & Development Tax Incentive Refund of A$3.3 million in cash under the Australian Government?s tax incentive scheme. In the announcement dated 18 March 2019, Pr...

 Ramsay Health Care Released Investor Presentation For European Operations

Ramsay Health Care Released Investor Presentation For European Operations

March 18, 2019 02:38 PM AEDT| By Team Kalkine Media

The Sydney-based Ramsay Health Care Limited (ASX: RHC), established in 1964, offers health care services to patients in the public and private sector. The services include day surgery procedures, complex surgeries, psychiatric care and rehabilitation...

 Next Science Limited to raise $35 Million via IPO – A Quick Look

Next Science Limited to raise $35 Million via IPO – A Quick Look

March 18, 2019 01:40 PM AEDT| By Team Kalkine Media

Australia-based medical technology company, Next Science Limited (ASX Proposed: NXS) is all set to raise A$35 million via IPO and list on ASX in the next month. The company has already launched its offer on 15 March 2019 in which it has invited its i...

 5 Small Cap Healthcare Stocks - KZA, TLX, BNO, NAN And IMU

5 Small Cap Healthcare Stocks - KZA, TLX, BNO, NAN And IMU

March 17, 2019 10:15 AM AEDT| By Team Kalkine Media

Kazia Therapeutics Ltd (ASX: KZA) Kazia Therapeutics Ltd (ASX: KZA), a biotechnology company that operates in the arena of oncology (cancer), for the first half of FY 19 has reported 56.5% decline in the operating revenue to $28,831. The company for...

 3 Healthcare Stocks - RHC, RMD And SHL

3 Healthcare Stocks - RHC, RMD And SHL

March 16, 2019 06:13 PM AEDT| By Team Kalkine Media

Ramsay Healthcare Limited (ASX: RHC) Ramsay Healthcare Limited (ASX: RHC) has recently presented its Ramsay Health Care UK business prospect in the investor day program and highlighted about 1HFY19 activity and its growth strategy. According to the...

 Zoono Group’s Share Surge Over 40% Post Agreement With Midas Pharma Announcement

Zoono Group’s Share Surge Over 40% Post Agreement With Midas Pharma Announcement

March 15, 2019 07:32 PM AEDT| By Team Kalkine Media

Zoono Group Limited (ASX: ZNO) today announced that it has entered into an agreement with Midas Pharma GmbH in Ingelheim, Germany. The agreement aims to bring both parties together for sales and distribution in the EU and selected global markets. Mi...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.